Your browser doesn't support javascript.
loading
Survival in malignant astrocytoma at King Khalid University Hospital
Annals of Saudi Medicine. 1995; 15 (3): 231-5
in English | IMEMR | ID: emr-36313
ABSTRACT
Malignant astrocytoma [Kernohan grade III and IV] still has one of the worst outcomes of all malignant tumors. To determine factors affecting the survival of patients with malignant astrocytoma in Saudi Arabia, a retrospective study of 76 cases that were treated at King Khalid University Hospital over one decade was carried out. Kaplan-Meier survival diagrams were constructed for each prognostic factor. Twenty-eight percent of cases survived two years. A significantly better survival rate was found in females, patients patients who had re-operation for a recurrence. A better survival rate which did not reach significance was found in patients with grade III tumors, patients with a Karnofsky score of >/= 70 at presentation, patients who had craniotomy and excision and patients who had radiotherapy. It is suggested that to improve the outcome of patients with malignant astrocytoma, aggressive surgical excision with radiotherapy [and possibly chemotherapy] is required
Subject(s)
Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Survival Analysis / Glioblastoma / Neoplasms Language: English Journal: Ann. Saudi Med. Year: 1995

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Survival Analysis / Glioblastoma / Neoplasms Language: English Journal: Ann. Saudi Med. Year: 1995